A detailed history of Pya Waltman Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pya Waltman Capital, LLC holds 3,925 shares of BMY stock, worth $226,001. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,925
Holding current value
$226,001
% of portfolio
0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$39.66 - $51.75 $155,665 - $203,118
3,925 New
3,925 $203,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $30,681 - $34,306
-530 Reduced 11.9%
3,925 $227,000
Q2 2023

Aug 15, 2023

BUY
$63.71 - $70.74 $33,766 - $37,492
530 Added 13.5%
4,455 $284,000
Q4 2021

Feb 07, 2022

BUY
$53.63 - $62.52 $210,497 - $245,391
3,925 New
3,925 $245,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pya Waltman Capital, LLC Portfolio

Follow Pya Waltman Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pya Waltman Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pya Waltman Capital, LLC with notifications on news.